News
TORONTO, ON / ACCESS Newswire / July 29, 2025 / Highlander Silver Corp. (TSX:HSLV) (“Highlander Silver” or the “Company“) is ...
Many Americans face a significant retirement savings gap and risk relying solely on Social Security. Read about how dividends ...
Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent.
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...
Sean “Diddy” Combs ' recent ex-girlfriend described enduring drug-fueled sex marathons until the hip-hop titan's arrest in September as the key witness began testimony Thursday soon after the ...
Discover Q2 2025 insights on ICON Public Limited Company (ICLR), featuring revenue growth, digital innovation, biotech partnerships, and cautious ...
Q2 2025 Earnings Call Transcript July 23, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the ...
The French biotech is developing a new drug approach in a disease market that’s projected to grow to $30 billion by 2030.
Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...
Q2 2025 Earnings Call Transcript July 22, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $2.81, ...
PepsiCo, Inc. (NASDAQ:PEP) is making bold operational shifts across its global portfolio as it navigates shifting demand ...
A trial testing a nerve-sparing (NeuroSAFE) technique in radical prostatectomy may improve patient-reported outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results